RaySearch Laboratories AB (0GRZ) Ratios
RaySearch Laboratories AB Ratios
GB:0GRZ's free cash flow for Q2 2026 was $126.60M. For the 2026 fiscal year, GB:0GRZ's free cash flow was decreased by $-6.70M and operating cash flow was $133.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.70 | 1.40 | 1.19 | 1.02 | 1.05 |
| Quick Ratio | 1.66 | 1.38 | 1.17 | 1.00 | 0.99 |
| Cash Ratio | 0.71 | 0.66 | 0.51 | 0.26 | 0.21 |
| Solvency Ratio | 0.52 | 0.41 | 0.30 | 0.26 | 0.19 |
| Operating Cash Flow Ratio | 0.68 | 0.69 | 0.68 | 0.58 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 11.20 |
| Net Current Asset Value | $ -36.00M | $ -229.73M | $ -414.99M | $ -590.87M | $ -573.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.23 | 0.27 | 0.30 | 0.32 |
| Debt-to-Equity Ratio | 0.40 | 0.54 | 0.72 | 0.85 | 0.89 |
| Debt-to-Capital Ratio | 0.29 | 0.35 | 0.42 | 0.46 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.02 | 2.39 | 2.66 | 2.85 | 2.77 |
| Debt Service Coverage Ratio | 70.87 | 56.59 | 38.96 | 28.95 | 7.64 |
| Interest Coverage Ratio | 41.26 | 28.80 | 11.86 | 3.72 | -8.72 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 11.75 | 14.03 | 15.72 | 16.53 | 16.55 |
| Net Debt to EBITDA | -0.02 | 0.02 | 0.46 | 1.16 | 2.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.77% | 91.65% | 89.57% | 88.74% | 92.15% |
| EBIT Margin | 23.94% | 22.81% | 11.24% | 5.20% | -8.20% |
| EBITDA Margin | 45.59% | 47.93% | 39.71% | 40.40% | 30.76% |
| Operating Profit Margin | 23.94% | 21.85% | 11.24% | 5.07% | -8.20% |
| Pretax Profit Margin | 21.41% | 22.05% | 10.77% | 3.84% | -9.14% |
| Net Profit Margin | 16.95% | 17.07% | 7.98% | 2.82% | -7.37% |
| Continuous Operations Profit Margin | 16.95% | 17.07% | 7.98% | 2.82% | -7.37% |
| Net Income Per EBT | 79.15% | 77.42% | 74.10% | 73.45% | 80.64% |
| EBT Per EBIT | 89.43% | 100.91% | 95.83% | 75.74% | 111.47% |
| Return on Assets (ROA) | 11.44% | 9.73% | 4.18% | 1.27% | -2.72% |
| Return on Equity (ROE) | 23.12% | 23.21% | 11.09% | 3.62% | -7.53% |
| Return on Capital Employed (ROCE) | 22.63% | 18.78% | 8.99% | 3.39% | -4.21% |
| Return on Invested Capital (ROIC) | 16.99% | 13.77% | 6.19% | 2.34% | -3.22% |
| Return on Tangible Assets | 15.89% | 13.19% | 5.74% | 1.75% | -3.89% |
| Earnings Yield | 2.92% | 2.75% | 2.63% | 1.02% | -2.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.48 | 2.55 | 2.54 | 2.12 | 1.81 |
| Payables Turnover | 11.10 | 2.57 | 2.53 | 3.95 | 1.03 |
| Inventory Turnover | 17.86 | 9.37 | 11.44 | 6.74 | 1.68 |
| Fixed Asset Turnover | 3.01 | 2.26 | 1.73 | 1.30 | 0.96 |
| Asset Turnover | 0.67 | 0.57 | 0.52 | 0.45 | 0.37 |
| Working Capital Turnover Ratio | 3.94 | 5.84 | 14.48 | 42.06 | 7.32 |
| Cash Conversion Cycle | 134.55 | 40.12 | 31.26 | 134.12 | 66.12 |
| Days of Sales Outstanding | 147.00 | 143.34 | 143.47 | 172.31 | 202.15 |
| Days of Inventory Outstanding | 20.44 | 38.96 | 31.92 | 54.14 | 217.21 |
| Days of Payables Outstanding | 32.89 | 142.19 | 144.13 | 92.33 | 353.25 |
| Operating Cycle | 167.44 | 182.30 | 175.39 | 226.45 | 419.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 11.30 | 14.15 | 13.30 | 10.41 | 6.95 |
| Free Cash Flow Per Share | 10.48 | 7.81 | 7.19 | 3.65 | -0.50 |
| Dividend Paid and CapEx Coverage Ratio | 2.96 | 1.70 | 2.18 | 1.54 | 0.93 |
| Capital Expenditure Coverage Ratio | 13.77 | 2.23 | 2.18 | 1.54 | 0.93 |
| Operating Cash Flow Coverage Ratio | 0.98 | 1.03 | 0.86 | 0.64 | 0.42 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.41 | 0.45 | 0.42 | 0.37 |
| Free Cash Flow Yield | 4.60% | 3.61% | 7.97% | 5.37% | -0.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 34.29 | 36.36 | 37.95 | 98.04 | -40.94 |
| Price-to-Sales (P/S) Ratio | 5.81 | 6.21 | 3.03 | 2.76 | 3.02 |
| Price-to-Book (P/B) Ratio | 7.93 | 8.45 | 4.21 | 3.55 | 3.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.76 | 27.66 | 12.55 | 18.61 | -113.54 |
| Price-to-Operating Cash Flow Ratio | 20.18 | 15.26 | 6.79 | 6.53 | 8.13 |
| Price-to-Earnings Growth (PEG) Ratio | 2.87 | 0.24 | 0.15 | -0.65 | -0.10 |
| Enterprise Value Multiple | 12.72 | 12.98 | 8.08 | 8.00 | 12.14 |
| Enterprise Value | 7.80B | 7.41B | 3.28B | 2.73B | 2.40B |
| EV to EBITDA | 12.72 | 12.98 | 8.08 | 8.00 | 12.14 |
| EV to Sales | 5.80 | 6.22 | 3.21 | 3.23 | 3.73 |
| EV to Free Cash Flow | 21.73 | 27.70 | 13.31 | 21.76 | -140.44 |
| EV to Operating Cash Flow | 20.15 | 15.28 | 7.20 | 7.64 | 10.06 |
| Tangible Book Value Per Share | 12.45 | 9.58 | 5.97 | 4.04 | 3.68 |
| Shareholders’ Equity Per Share | 28.76 | 25.57 | 21.45 | 19.17 | 18.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.23 | 0.26 | 0.27 | 0.19 |
| Revenue Per Share | 39.24 | 34.77 | 29.82 | 24.61 | 18.72 |
| Net Income Per Share | 6.65 | 5.94 | 2.38 | 0.69 | -1.38 |
| Tax Burden | 0.79 | 0.77 | 0.74 | 0.73 | 0.81 |
| Interest Burden | 0.89 | 0.97 | 0.96 | 0.74 | 1.11 |
| Research & Development to Revenue | 0.04 | 0.23 | 0.23 | 0.28 | 0.36 |
| SG&A to Revenue | 0.48 | 0.48 | 0.19 | 0.20 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.70 | 2.38 | 5.59 | 15.00 | -4.06 |
Currency in SEK
